Beckman Research Institute Of The City Of Hope
- Assets
- $2.0b
- Revenue
- $339.2m
- Investments
- $912.7m
- Employees
- 1,243
- Location
- Duarte, CA
- Founding
- 03/2005
- Data as of
- 09/2021
- EIN
- 95-3432210
Organization Overview
Beckman Research Institute Of The City Of Hope is located in Duarte, CA. The organization was established in 2005. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 09/2021, Beckman Research Institute Of The City Of Hope employed 1,243 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Beckman Research Institute Of The City Of Hope is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2021, Beckman Research Institute Of The City Of Hope generated $339.2m in total revenue. The organization has seen a slow decline revenue. Over the past 6 years, revenues have fallen by an average of (1.5%) each year. All expenses for the organization totaled $341.8m during the year ending 09/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO DISCOVER AND TRANSLATE INNOVATIVE LABORATORY FINDINGS INTO NEW CLINICAL TREATMENTS BY USING PRACTICAL APPLICATIONS OF CHEMISTRY, PHYSICS AND BIOLOGY.
Describe the Organization's Program Activity:
BIOMEDICAL RESEARCH AND DISEASE INVESTIGATIONS, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS. BECKMAN RESEARCH INSTITUTE HAS PIONEERED SCIENTIFIC BREAKTHROUGHS RESULTING IN TREATMENTS THAT HAVE IMPROVED THE LIVES OF PATIENTS WORLDWIDE. NUMEROUS LIFE-SAVING DRUGS USE PATENTED TECHNOLOGY DEVELOPED AT BECKMAN RESEARCH INSTITUTE. THESE DRUGS INCLUDE SYNTHETIC HUMAN INSULIN (HUMULIN) FOR DIABETES, THE WIDELY USED CANCER DRUGS HERCEPTIN, RITUXAN AND AVASTIN, AND HUMIRA FOR ARTHRITIS. SEE SCHEDULE O.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Steven T Rosen MD Provost/cancer Center Director | Officer | 34 | $892,589 |
Robert W Stone President/ceo | Officer | 15 | $786,874 |
David A Horne PHD Vice Provost | Officer | 51 | $577,418 |
Harlan Levine Pres Strategy & Bus Ventures | 18 | $551,516 | |
Linda Helen Malkas PHD Board Member/professor | Trustee | 60 | $407,801 |
Ashley Baker Lee SVP Of Research Operations | Officer | 30 | $386,859 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Conam Building Co Construction Svcs | 9/29/21 | $4,235,696 |
Durie Tangri Llp Legal Services | 9/29/21 | $2,173,404 |
Mintz Levin Cohn Ferris Glovsky P Legal Services | 9/29/21 | $2,872,983 |
Jones Day Legal Services | 9/29/21 | $1,287,632 |
Fish Richardson Pc Legal Services | 9/29/21 | $925,033 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $87,697,589 |
| Government grants | $90,898,031 |
| All other contributions, gifts, grants, and similar amounts not included above | $6,493,877 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $185,089,497 |
| Total Program Service Revenue | $17,733,869 |
| Investment income | $10,703,832 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $24,049,860 |
| Net Rental Income | $51,200 |
| Net Gain/Loss on Asset Sales | $97,918,904 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $339,177,936 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $5,359,144 |
| Compensation of current officers, directors, key employees. | $3,503,864 |
| Compensation to disqualified persons | $186,021 |
| Other salaries and wages | $141,292,557 |
| Pension plan accruals and contributions | $9,327,453 |
| Other employee benefits | $16,125,392 |
| Payroll taxes | $8,151,663 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $9,791,749 |
| Fees for services: Accounting | $294,383 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $2,817,568 |
| Fees for services: Other | $33,551,266 |
| Advertising and promotion | $2,219,655 |
| Office expenses | $33,658,705 |
| Information technology | $7,522,004 |
| Royalties | $0 |
| Occupancy | $11,859,667 |
| Travel | $290,451 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $257,658 |
| Interest | $200,239 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $27,675,064 |
| Insurance | $594,762 |
| All other expenses | $7,500,128 |
| Total functional expenses | $341,846,245 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,681,035 |
| Savings and temporary cash investments | $71,476,960 |
| Pledges and grants receivable | $55,481,838 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $5,377,157 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $301,461 |
| Net Land, buildings, and equipment | $310,505,148 |
| Investments—publicly traded securities | $547,030,523 |
| Investments—other securities | $912,730,798 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $89,243,162 |
| Total assets | $1,995,828,082 |
| Accounts payable and accrued expenses | $54,947,308 |
| Grants payable | $0 |
| Deferred revenue | $10,894,125 |
| Tax-exempt bond liabilities | $50,723,925 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $50,000,000 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $371,111,229 |
| Total liabilities | $537,676,587 |
| Net assets without donor restrictions | $1,427,028,168 |
| Net assets with donor restrictions | $31,123,327 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,995,828,082 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Beckman Research Institute Of The City Of Hope has recieved totaling $80,000.
| Awarding Organization | Amount |
|---|---|
Diabetes Action Research And Education Foundation Bethesda, MD PURPOSE: RESEARCH | $80,000 |
Endowment Analysis
| Beg. Balance | $813,672,523 |
| Earnings | $225,523,936 |
| Net Contributions | $30,000 |
| Other Expense | $271,219 |
| Ending Balance | $1,038,955,240 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Beckman Research Institute Of The City Of Hope Duarte, CA | $1,995,828,082 | $339,177,936 |
Jonsson Cancer Center Foundation- Ucla Los Angeles, CA | $29,334,497 | $13,187,047 |
Translational Research In Oncology Us Inc Los Angeles, CA | $23,537,777 | $8,265,596 |
Pediatric Cancer Research Foundation Irvine, CA | $3,627,407 | $2,821,956 |
Nevada Cancer Research Foundation Inc Las Vegas, NV | $637,661 | $2,412,271 |
The International Genomics Consortium Phoenix, AZ | $13,871,737 | $3,350,681 |
Cancer Prevention Institute of California (CPIC) Foster City, CA | $0 | $44,595 |
Vanguard Cancer Foundation Long Beach, CA | $1,374,337 | $177,388 |
Prostate Cancer Research Institute Culver City, CA | $2,240,081 | $999,786 |
Keatons Child Cancer Alliance Roseville, CA | $375,909 | $787,785 |
Ethos Discovery San Diego, CA | $1,024,175 | $920,855 |
Sino-American Cancer Foundation Arcadia, CA | $0 | $1,131,529 |